Dr Harald Janovjak has been awarded a JDRF project grant for his innovative work using light as a new strategy to treat type 1 diabetes. The EMBL Australia Group Leader’s work is the first application of visible light treatment to the insulin-making beta cells that are destroyed in type 1 diabetics.
Keep up to date with all the latest EMBL Australia news and events.